ArticleCytometry. Part B, Clinical cytometry2022

Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis.

Kah Teong Soh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.